Swedish Orphan Biovitrum total liabilities and share holders equity for the quarter ending September 30, 2024 was $6.931B, a 0.85% decline year-over-year.
Swedish Orphan Biovitrum total liabilities and share holders equity for 2023 was $6.981B, a 34.18% increase from 2022.
Swedish Orphan Biovitrum total liabilities and share holders equity for 2022 was $5.202B, a 8.31% decline from 2021.
Swedish Orphan Biovitrum total liabilities and share holders equity for 2021 was $5.674B, a 7.81% increase from 2020.
Swedish Orphan Biovitrum Total Liabilities and Share Holders Equity 2019-2024 | BIOVF